Abstract
The effect of antimicrobials on SOS-mediated mutagenesis induction depends on the bacterial species and the antimicrobial group. In this work, we studied the effect of different families of antimicrobial agents used in clinical therapy against Acinetobacter baumannii in the induction of mutagenesis in this multiresistant Gram-negative pathogen. The data showed that ciprofloxacin and tetracycline induce SOS-mediated mutagenesis, whereas colistin and meropenem, which are extensively used in clinical therapy, do not.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter Infections / drug therapy
-
Acinetobacter Infections / microbiology
-
Acinetobacter baumannii / drug effects*
-
Acinetobacter baumannii / genetics*
-
Anti-Bacterial Agents / pharmacology*
-
Ciprofloxacin / pharmacology
-
Colistin / pharmacology
-
Colony Count, Microbial
-
Drug Resistance, Bacterial / drug effects*
-
Drug Resistance, Bacterial / genetics*
-
Humans
-
Meropenem
-
Microbial Sensitivity Tests
-
Mutagenesis / drug effects
-
Rifampin / pharmacology
-
SOS Response, Genetics / drug effects*
-
Tetracyclines / pharmacology
-
Thienamycins / pharmacology
Substances
-
Anti-Bacterial Agents
-
Tetracyclines
-
Thienamycins
-
Ciprofloxacin
-
Meropenem
-
Rifampin
-
Colistin